By proceeding, you agree to our Terms of Use and Privacy Policy.
Team leader with strategic and technical experience across the drug development life cycle, including target identification & validation, in vitro & in vivo pharmacology, preclinical development, and translational biology.
Talks About #biotechnology #biology
Preferred Locations #Northamerica
The surge of clinical approvals in CKD and unprecedented use of surrogate endpoints in rare kidney diseases have catalysed a new era of complimentary therapies and precision medicine in drug development for kidney disease.
